We are live on ! Find out more
NUVA

NuVasive, Inc.

Delisted

NUVA was delisted on the 31st of August, 2023.

260 hedge funds and large institutions have $3.05B invested in NuVasive, Inc. in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 85 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $5.06M

30% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 30

2% more funds holding

Funds holding: 255260 (+5)

6% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 85

3% more capital invested

Capital invested by funds: $2.97B → $3.05B (+$78.6M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
260
Holders Change
+5
Holders Change %
+1.96%
% of All Funds
5.65%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
39
Increased
90
Reduced
85
Closed
30
Calls
$10.7M
Puts
$5.06M
Net Calls
+$5.66M
Net Calls Change
+$12.4M

NUVA Hedge Fund Activity: Q2 2019 in Review

260 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2019, worth a combined $3.05B — up 2.6% from $2.97B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new NUVA positions and 30 closed out — a net gain of 9 holders — while 90 added to existing stakes and 85 trimmed.

The largest buyer was Eminence Capital, opening a new position worth an estimated $70.7M. The largest seller was Champlain Investment Partners, cutting an estimated $44.6M.

  • 260 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2019, up from 255 in Q1 2019.
  • Funds reported $3.05B of NuVasive, Inc. stock for Q2 2019, up 2.6% quarter-over-quarter.
  • 39 funds opened new NuVasive, Inc. positions in Q2 2019 and 30 closed out, a net change of +9 holders.
  • The largest NuVasive, Inc. buyer in Q2 2019 was Eminence Capital, an estimated $70.7M added.
  • The largest NuVasive, Inc. seller in Q2 2019 was Champlain Investment Partners, an estimated $44.6M sold.

Based on aggregated 13F filings for Q2 2019.